Interferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent Non-Hodgkin Lymphomas Patients Using Daclatasvir and Asunaprevir: A Pilot Study
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 07 Sep 2017
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Sep 2017 Last checked against ClinicalTrials.gov record.
- 01 Sep 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 13 Jul 2017 New trial record